RxSight Inc (RXST)
45.05
+0.24
(+0.54%)
USD |
NASDAQ |
Nov 21, 16:00
45.03
-0.02
(-0.04%)
After-Hours: 20:00
RxSight Enterprise Value: 1.579B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 1.579B |
| November 20, 2024 | 1.569B |
| November 19, 2024 | 1.581B |
| November 18, 2024 | 1.563B |
| November 15, 2024 | 1.579B |
| November 14, 2024 | 1.543B |
| November 13, 2024 | 1.562B |
| November 12, 2024 | 1.595B |
| November 11, 2024 | 1.630B |
| November 08, 2024 | 1.698B |
| November 07, 2024 | 1.812B |
| November 06, 2024 | 1.969B |
| November 05, 2024 | 1.848B |
| November 04, 2024 | 1.828B |
| November 01, 2024 | 1.822B |
| October 31, 2024 | 1.805B |
| October 30, 2024 | 1.827B |
| October 29, 2024 | 1.863B |
| October 28, 2024 | 1.786B |
| October 25, 2024 | 1.791B |
| October 24, 2024 | 1.758B |
| October 23, 2024 | 1.716B |
| October 22, 2024 | 1.787B |
| October 21, 2024 | 1.797B |
| October 18, 2024 | 1.795B |
| Date | Value |
|---|---|
| October 17, 2024 | 1.777B |
| October 16, 2024 | 1.802B |
| October 15, 2024 | 1.760B |
| October 14, 2024 | 1.786B |
| October 11, 2024 | 1.784B |
| October 10, 2024 | 1.772B |
| October 09, 2024 | 1.749B |
| October 08, 2024 | 1.745B |
| October 07, 2024 | 1.705B |
| October 04, 2024 | 1.731B |
| October 03, 2024 | 1.689B |
| October 02, 2024 | 1.677B |
| October 01, 2024 | 1.661B |
| September 30, 2024 | 1.753B |
| September 27, 2024 | 1.693B |
| September 26, 2024 | 1.707B |
| September 25, 2024 | 1.708B |
| September 24, 2024 | 1.707B |
| September 23, 2024 | 1.813B |
| September 20, 2024 | 1.869B |
| September 19, 2024 | 1.893B |
| September 18, 2024 | 1.916B |
| September 17, 2024 | 1.995B |
| September 16, 2024 | 1.971B |
| September 13, 2024 | 1.948B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
125.91M
Minimum
Jan 07 2022
2.398B
Maximum
May 15 2024
823.36M
Average
470.83M
Median
Enterprise Value Benchmarks
| Tandem Diabetes Care Inc | 1.894B |
| Perspective Therapeutics Inc | -63.40M |
| Retractable Technologies Inc | -17.27M |
| Xtant Medical Holdings Inc | 85.83M |
| Catheter Precision Inc | 3.891M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.338M |
| Revenue (Quarterly) | 35.31M |
| Total Expenses (Quarterly) | 44.54M |
| EPS Diluted (Quarterly) | -0.16 |
| Gross Profit Margin (Quarterly) | 71.42% |
| Profit Margin (Quarterly) | -17.95% |
| Earnings Yield | -1.82% |
| Normalized Earnings Yield | -1.820 |